Vol. 01 Issue 05, September-October 2017

FEATURES

Cleveland Clinic

retains top position for

heart care

NEWS & UPDATES

Switzerland: Consumer-driven healthcare system

HEALTH DESTINATION

Creating the ideal Creating the ideal

healthcare healthcare infrastructure infrastructure Faizal E. Kottikollon; Founder, Chairman & CEO, KEF Holdings Limited

Exponential growth in ultrasonography

in emergency medicine

• Design • Supply • Supervision • Installation • Training • Third Party Inspection • Testing & Commissioning • Operation & Maintenance

Live

MGPS Training

NewDubai Training

Center

Aras Eastwood Park is a dedicated training company specialised in medical & laboratory gas engineering system.

MEDICAL ENGINEERING DIVISIONis the core of our business with a sound project management infrastructure. We offer a complete engineering solution for Medical/Laboratory Gas Engineering Pipeline System (MGPS/LGEPS)

INDUSTRIAL DIVISION• Compressed Air System • Screw Compressor • Piston Compressor • Solenoid Valves • Vacuum pumps • Pneumatics • Filters

Healthcare Division

Training Offered :Pre Qualifying course for (HTM-02-01)Competent Person MGPS installation (HTM-02)

Executive Managers (HTM-02)

Operations Manager (HTM-02)

Competent Person MGPS maintenance (HTM-02)

Authorized person MGPS design installation & maint. (HTM-02)

Authorized person General New Hospital Engineers & Supervisors

Medical Gas Technician MGPS (HTM-02)

Quality Controller MGPS (HTM-02)

Nurse MGPS (HTM-02)

Designated Medical Officer

Sheikha Mahra Ahmad Al Ghurair Building, Above Al Hilal Bank, First Floor, Office 102, Al Nahda Road, Al Qusais, Dubai.Tel: +971 4 23 44457 | Fax: +971 4 23 44458 | Mob: +971 50 646 2583 | E-mail: training@arasgroup.ae | Web: www.arasgroup.ae

Branches: MIDDLE EAST & NORTH AFRICA| USA | ASIA | SOUTH EAST ASIA

Aras Group

Published Bi-Monthly: Vol 01 | Issue 5 | No. 05Middle East, Africa and Asia & Beyond

Chief Editor Rustu Soydanrustu�mediworldme.com

Contributors Nirmala RaoAyesha Rashidayesha�aircargoupdate.comAkbar Ali - Senior Correspondentakbar��dimensionsmedia.com Sales � Marketing Israr Ahmad israr��dimensionsmedia.comTousif Ahmad tousif��dimensionsmedia.com

Head OperationsJamal Ahmadjamal��dimensionsmedia.com

Photographer�sJamal � Wasim Creative HeadMohammed Imran

MediWorld ME aims to create the ultimate platform to share the

latest news, updates & developments from the healthcare &

medical technology industry within & beyond the GCC countries

Editorial

Editor’s NoteMediWorld Middle East has entered into a new phase after receiving strong support and positive feedback from healthcare industry leaders, researchers, professionals and readers. The magazine is committed to cover the latest developments in healthcare projects and facil it ies, innovative designs, medical technology, pharmaceutical and other relevant industries. Our reports and features are driven through research into major trends and interview with industry leaders, experts, stakeholders and decision makers.

Our magazine available in both print and online is a perfect platform for advertisers who use Middle East Health as a key vehicle to show their products and services and increase brand awareness in the region. Healthcare leaders face constant and ever-growing demands across an increasingly multi-faceted healthcare system. Leaders need to be equipped with the knowledge and skills to respond to these challenges.

Healthcare projects worth $55.2billion are currently in the pipeline in the Mena region. A total of 37 mega hospital projects worth about $28.2 billion are already underway in the Gulf region, and these are expected to add 22,500 hospital beds to existing capacity, says Alpen Capital Healthcare Report.

The UAE gives top priority to its healthcare facilities and infrastructure. The healthcare market in the country is reportedly expected to be valued at $19.5 billion by 2020, achieving an annual average growth of 12 per cent, which is the strongest growth in the GCC region.

Faizal E. Kottikollon, Founder, Chairman and Chief Executive Officer, KEF Holdings Limited, suggested an ideal method for building hospital infrastructure during an interview with MediWorld Middle East. This method is based on turnkey, design and build solutions.

A breakthrough to �ght deadly infectious disease is a good news. Aethlon Medical has created Hemopuri�er, an innovative medical device, to eliminate life-threatening diseases such as Ebola and HIV. Read the article in our magazine and learn more about the capabilities of the device and how it battles Ebola and HIV.

An article on exponential growth in ultrasonography in emergency medicine will shed some light on the importance of the diagnostic imaging techniques in healthcare culture. Now women can put their hands on the remote control button of mammography device to choose the compression rate. The device known as 'Senographe Pristina Dueta' is introduced by GE Healthcare and approved by FDA

According to Siemens Healthcare, breast cancer is growing throughout the world and breast cancer screening is expected to reach 250 million next year.

Read our news update section and your feedback will be highly appreciated. We will focus more on building new healthcare infrastructure and innovative designs in our next edition.

Sincerely,

Editor, MediWorld ME

03

DISCLAIMER: All rights reserved. The opinions and views express in this publication are not

necessarily those of the publishers. Readers are request to seek specialist advice before acting

on information contained in the publication, which is provided for general use and may not be

appropriate for the reader’s particulars circumstances. The publishers regret that they cannot

accept liability for any error or omissions contained in this publication.

06-Cover�StoryCreating�the�ideal�healthcare�infrastructure�

Contents

For�the�latest�News�&�Updates�visit:�www.mediworldme.com

10-Feature��Combat against life-threatening diseases

14-Feature�Exponential growth in Ultrasonography in emergency medicine

Sep-Oct 2017

26-Budapest Airport supports Cool Chain and Air Cargo Handling Conference

36-Quick�References�

35-Events�Calendar�

Medical Destination 22- Switzerland: Consumer-driven healthcare system

34-Surgical pen can detect cancer in seconds

26-34�News�&�Updates

Sharjah�launches�health�awareness�campaign

Treating�insomnia�can�ease�depression�and�paranoia

Fast�food�chain�cut�global�antibiotic�use�in�chickens

UAE's�Julphar�names�Laurent�de�Chazeaux�as�acting�CFO

NMC�to�manage�Emirates�Healthcare�assets

Safe�transportation�and�disposal�of�hazardous�and�medical�wastes�urged

Cover Story

06

Creating the ideal

healthcareinfrastructure With the UAE boasting the strongest growth rate in healthcare sector, billions of dollars are being poured into new projects in MENA to build top facilities for patients both from within and outside the region

o ensure that the healthcare infrastructure is well Tin place and according to the guidelines, the infrastructure should convey a positive message

to its patients, visitors, volunteers and staffs about what the facility and medical care is being provided there. An ideal message should be welcoming, caring, comforting with compassion and commitment to patient well-being and safety, healthcare experts highlight.

The UAE healthcare market is reportedly expected to be

valued at $19.5 billion by 2020, achieving an annual

average growth of 12.7 per cent, which is the strongest

growth rate in the GCC region, industry statistics

highlight. Just some of the measures being taken to

drive growth in the sector by the government include

encouraging private sector participation to build

hospitals and clinics and introducing mandatory health

insurance for everyone. The PPP model will grow

increasingly popular in the years to come as private

sector investment will be encouraged.

MediWorld ME recently met with Faizal E. Kottikollon,

Founder, Chairman and Chief Executive Officer, KEF

Holdings Limited to discuss what an ideal healthcare

structure looks like in the UAE and beyond.

King Faisal Medical City, Saudi Arabia

07

Ideal healthcare infrastructure

Over the years, healthcare projects have been designed and built primary on immediate and at the best near future needs. According to National Institute of Building Sciences, an ideal healthcare infrastructure has a life span of 50 – 100 years or more. The forces that influence the need for flexibility are numerous and ever-evolving.

“Investors are always looking to reduce costs and shorten construction schedules without compromising high-quality design and finishes. The move toward more standardized environments and systematic approaches to care delivery makes offsite manufacturing, where 90 per cent of the hospital is manufactured in a controlled factory environment and assembled onsite, the ideal method for building hospital infrastructure. This reduces construction time by up to 50 percent which allows for significant return on investment for the project.

In the UAE, this approach has not been adopted so far in totality in the healthcare industry. At KEF, we see a huge opportunity in this respect, which is why our focus is set on bringing turnkey, design and build, infrastructure solutions to the Emirates,” Mr Kottikollon explained.

Physical environment

Many construction experts have identified that physical environment has a significant impact on safety and human per formance, the tools used, and the environment in which they live and work is basic to any study of the design a healthcare facility and its effect on the performance of the nurses and other caregivers who interface with the facility and its fixed (e.g., oxygen and suctioning ports on the wall of a patient room) and moveable (e.g., a patient bed) equipment and technology.

The design of a facility with its fixed and moveable components can have a significant impact on human performance, especially on the health and safety of employees, patients and families. In a review of more than 600 articles, researchers found that there was a link between the physical environment (i.e., single-bed or multiple-bed patient rooms) and patient (e.g., fewer adverse events and better health care quality) and staff outcomes (e.g., reduced stress and fatigue and increased effectiveness in delivering care).

Efforts to improve patient and staff outcomes can target latent conditions for clinicians by using evidence-based

designs to decrease distractions, standardize locations of equipment and supplies, and ensure adequate space for documentation and work areas. The research done by

'Reason and Leape' describes the value of practices based on principles designed to compensate for human cognitive failings.

Operation and management

Growing evidence advocates the fact that physical environment impacts patient stress, patient and staff safety, staff effectiveness, patient satisfaction and quality of care provided in hospitals. Based on such research findings, KEF takes informed design decisions on the built environment of any healthcare facility, through its infrastructure arm, KEF Infra.

“On the other hand, our Healthcare division, KEF Health, advocates evidence-based clinical care to reduce variability, and consistently improve efficiencies of outcomes at a lower cost through designing optimal, evidence-based care paths. In developed markets, offsite and modular construction is fast replacing one-off design & conventional healthcare construction methodologies. Recent years have seen the emergence of large-scale manufacturing, installation and assembly of high quality, affordable hospital units off-site. With modular healthcare construction, KEF expects to

The design of a facility with its fixed and moveable components can have a significant impact on human performance, especially on the health and safety of employees, patients and families. Researchers found that there was a link between the physical environment and patient and staff outcomes. - Faizal E. Kottikollon, Founder,

Chairman and Chief Executive Officer, KEF Holdings Limited

Cover Story

08

turnaround the economies in the healthcare sector, enabling a system of rapid delivery of affordable healthcare facilities,” the CEO noted.

KEF Health's philosophy extend far beyond in terms of efficient and effective operation, maintenance and evaluation of the healthcare system.

Efficiency and sustainability

In an ideal situation, the sustainability process should start right from the design stage, and continue through each step of development of the hospital.

Mr. Kottikollon continued, “In the case of offsite

manufacturing of hospitals, the time savings delivered in developing a healthcare facility results in significantly higher ROI for the investor. Moreover, the manufacturing processes, covering each element from the façade to furniture within the hospital, are undertaken in a controlled environment, where the margin of error and wastage is almost negligible.

Once the facility is handed over, the infrastructure which

builds on advanced BIM technology, can be monitored and managed – allowing even the slightest anomalies to be detected and any consequent errors to be avoided. In the long-run, healthcare facilities that have a foundation rooted in technology will go a long way in bringing about greater efficiencies in the patient experience.”

Considering other factors

With human factors in mind, there are several other aspects of the building environment that should be considered. In a review of the literature by Henriksen and Colleagues, the following design elements were

identified as critical in ensuring patient safety and quality care, based on the six quality aims of the Institute of Medicine's report, Crossing the Quality Chasm: A New Health System for the 21st Century includes patient centeredness, safety, effectiveness, efficiency & equity.

There have been five other significant reviews of the literature relating to the physical environment and patient outcomes. Nelson and Colleagues identified the need to reduce noise pollution and enhance factors that can shorten a patient's length of stay (e.g., natural lighting, care in new/remodeled units and access to music and views of nature); according to their study,

patients can benefit from the skilful utilization of music and artwork.

Ulrich and Colleagues found research that demonstrated that the design of a hospital can significantly improve patient safety by decreasing health care associated infections and medical errors. They also found that facility design can have a direct impact on patient and staff satisfaction, a patient's stress experience, and organization performance metrics. Three other reviews found that hospital design, particularly when single-bed rooms are employed, can enhance patient safety and create environments that are healthier for patients, families and staff by preventing injury from falls, infections and medical errors; minimizing environmental stressors associated with noise and inefficient room and unit layout; and using nature, colour, light and sound to control potential stressors.

Billions in investments

On a related note, healthcare projects worth $55.2 billion are currently in the pipeline in the Middle East and North Africa (MENA) region, according to latest industry estimates. A total of 37 mega hospital projects worth about $28.2 billion are already underway in the Gulf region, and these are expected to add 22,500 hospital beds to existing capacity according to Alpen Capital Healthcare Report. The rest of the year is expected to be even more robust for the healthcare projects market, with major projects being undertaken throughout the region, the report said.

Healthcare spending in MENA is expected to grow to $150 billion in 2020. In the GCC countries, it will account for about $70 billion of this spending with a compounded annual growth rate of over 12 per cent, one of the highest for any part of the world, according to global property consultant JLL.

Cover Story

The design of a hospital can significantly improve patient safety by decreasing health care associated infections and medical errors. The facility design can also have a direct impact on patient and staff satisfaction, a patient's stress experience and organization performance metrics, studies found.

The world spending on healthcare is expected to increase from $8 trillion in 2013 to $18 trillion in 2040, according to industry estimates. The demand for quality healthcare facilities in the MENA region has been growing dramatically.

Population growth is the key driving force that boost the demand for healthcare. The population of the region has increased by 1.9 per cent per annum, to reach approximately 470 million, which is well above the global average of 1.1 per cent. An ageing population acts as a further contributor.

Other factors include a need to increase healthcare spend as a percentage of GDP. The increasing prevalence of lifestyle diseases are expected to continue to drive the demand for healthcare services across the region. The development of the Health Insurance Sector, including governments making health insurance mandatory across the GCC by 2020 will act as a significant driver of further private sector investment.

Regional initiatives

Regional governments recognizing the need for this in the long term development of their countries have supported and invested in healthcare. Dubai in particular has been ahead of chart when it comes to setting up healthcare infrastructure. For e.g. Dubai Healthcare City the healthcare free zone was launched 15 years ago. There has also been a significant investment by the private sector in healthcare, recognizing the long term opportunity of this real estate asset class.

Another area that needs to be addressed as the healthcare industry grows a lot further is the need to have world class medical universities which would provide the human capital needed for regional growth to be sustained. The UAE is ranked 27 in world health systems as per the World Health Organization (WHO).

T h e UA E h e a l t h c a r e s e c t o r h a s d i s p l a y e d extraordinary growth and significant progress. The

Health Authority Abu Dhabi (HAAD), Abu Dhabi Health Services Company (SEHA) and Dubai Health Authority (DHA) have developed a highly efficient health service system that includes sophisticated physical infrastructure and cutting edge IT service.

According to Alpen, the healthcare market in the UAE is projected at $19.5 billion in 2020, indicating an annual average growth of 12.7 per cent from 2015. The outpatient and inpatient markets are projected to reach $12.1 billion and $7.5 billion, respectively, in 2020. The country is likely to see a nearly 3 per cent annual increase in the number of hospital beds required, presenting a demand of more than 13,800 beds by 2020.

In the UAE, some of the high-profile projects coming up include Al Ain Hospital in Al Ain, Burjeel Medical City in Abu Dhabi, Gulf Medical University Hospital in Ajman, Mediclinic Parview Hospital and King's College Hospital (KCH) in Dubai.

Projects in Saudi Arabia

The Saudi Arabian healthcare market is forecasted to reach $27.4 billion in 2020, registering a CAGR of 11 per cent from 2015. The outpatient and inpatient markets are expected at $15.2 billion and $12.2 billion respectively in 2020. From less than 70,000 in 2015, the number of beds required in the kingdom is likely to cross 76,500 in 2020.

Some of the latest hospital building projects in Saudi Arabia are King Abdullah Bin Abdulaziz, Project for Development of Security Forces Medical Complexes; King Khaled Medical City in Dammam; King Faisal Medical Cit in Asir; Mouwasat Hospital in Al Khobar and Amal Mental Health Hospital in Taif.

Saudi government is keen on developing and modernizing the healthcare industry on priority basis. It is encouraging the involvement of more private sector to improve the quality of healthcare. The Saudi health ministry has commissioned few projects to bridge the gap in healthcare infrastructure. The Kingdom offers

attractive opportunities to foreigners to invest in the country's healthcare facilities.

"The healthcare sector offers the ability for real estate investors to participate in a growing market backed by the government, where long-term leases can be structured to major regional and international healthcare providers," said Craig Plumb, head of research, MENA - JLL.

The MENA region has undoubtedly made significant strides in a relatively short period of time in the healthcare sector and with the continued focus in addressing the challenges by regional governments, the outlook for this sector continues to look upward.

Healthcare projects worth $55.2

billion are currently in the pipeline in

the MENA region. A total of 37 mega

hospital projects worth about $28.2

billion are already underway in the

Gulf region, and these are expected to

add 22,500 hospital beds to existing

capacity, says Alpen Capital

Healthcare Report.

09

Cover Story

The world spending on healthcare is

expected to increase from $8 trillion in

2013 to $18 trillion in 2040, according

to industry estimates. On a positive

note, the demand for quality

healthcare facilities in the MENA

region has been growing dramatically.

Burjeel Medical City, Abu Dhabi-UAE

10

Infectious diseases are disorders caused by organisations such as bacteria, virus,

fungi or parasites. Many organisations live in or on our bodies. They can be harmful or

harmless, but under certain conditions, some organisms may cause diseases.

Combat against deadly diseasesHemopurifier by Aethlon Medical aims to eliminate diseases such as Ebola and HIV

Feature

11

ome infectious diseases can be passed person Sto person; some are transmitted from insects or

animals. And other are acquired by ingesting

contaminated food or water or by being exposed to

organisms in the environment. Signs and symptoms

vary depending on the organism causing the infection,

but often include fever and fatigue. Mild infections

may respond to rest and home remedies while some

life-threatening infections may require severe

hospitalization.

Aethlon Medical recently created an innovative

medical device called Hemopurifier to combat against

life-threatening diseases such as Ebola and HIV.

James A. Joyce the Chairman and CEO of Aethlon

Medical explains to MediWorld ME the broad-

spectrum capabilities of Hemopurifier and how it

battles Ebola and HIV.

Single-use, disposable Hemopurifier

Emerging pathogens pose a significant threat to

mankind. Of the hundreds of viral pathogens known to

be infectious to man, only a few are addressed with

proven antiviral drug or vaccine therapies. Beyond the

looming threat of bioterrorism, a proliferation of

international travel, urban crowding and global

warming is expected to accelerate the emergence of

future pandemics.

James A. Joyce notes, “At present, no country is

prepared to address the breadth of viral pathogens

that could emerge naturally through mother-nature or

be released as an agent of bioterrorism by man. In fact,

only a small fraction of viruses that are already known

are addressed with an antiviral drug. Infectious

disease experts believe that a viral outbreak is the

most likely single event that could kill 10 million or

more people.”

The Hemopurifier is a single-use disposable cartridge

that Aethlon designed for use within the established

infrastructure of dialysis machines and other blood

circulatory instruments already located in hospitals

and clinical worldwide.

“The Aethlon Hemopurifier® is a first-in-class

medical device designed to rapidly eliminate

infectious viruses from the entire circulatory system.

The Hemopurifier is being advanced through the FDA

in the United States and has been proven to capture a

broad-spectrum of life-threatening viruses that are

not addressed with antiviral drug therapies, including

naturally occurring pandemic threats and agents of

bioterrorism. Hemopurifier is the first and only line of

defense and life-threatening viruses that are not

addressed with antiviral drug or vaccine therapies”.

Combatting viruses

The Hemopurifier addresses a wide range of viruses

as it captures infectious viruses by a common

structure that they cloak themselves with to evade the

surveillance of the immune system.

“As a result, we have an opportunity to address

different strains, species and families of viruses. In

addition to having success in treating ebola during the

recent outbreak, we have validated the capture of 16

high-threat viruses, of which most are not addressed

with a traditional drug therapy.”

To date, Hemopurifier therapy has been administered

to virally infected individuals for periods of four to six

and one-half hours. Unless patient is extremely ill,

they are able to read, listen or watch TV during which

treatment is being administered and do so in a relaxed

environment.

Broad-spectrum capabilities

According to experts, there is no cure for HIV, but there

are medications that can dramatically slow the

progression of the disease. But HIV continues to

At present, no country is prepared to address the breadth of viral pathogens that could emerge naturally through mother-nature or be released as an agent of bioterrorism by man. Infectious disease experts believe that a viral outbreak is the most likely single event that could kill 10 million or more people.

Feature

James A. Joyce, Chairman and CEO Aethlon Medical

12

decimate population in Africa, Haiti and parts of Asia.

HIV continues to be a major global public health issue,

having claimed more than 35 million lives so far. In

2016, 1 million people died from HIV-related caused

globally, according to WHO.

“Our research team has created an method that allows

us to quantity the number of viruses that are captured

in the Hemopurifier during treatment and no longer

circulating in the patient. This works for all RNA

viruses. In some cases, we have captured billions of

viruses within our device during single 4-6 hour

treatments.

Ebola is another rare but deadly virus that causes

fever, body aches and diarrhoea and sometimes

bleeding inside and outside the body. As the virus

spreads, it damages the immune system and organs,

ultimately causing levels of blood-clotting cells to

drop. This leads to severe uncontrollable bleeding. It

spreads through contact with skin or bodily fluids of

an infected animal like monkey, chimp or fruit bat.

However, according to experts again, there is no cure

for Ebola up until now. WHO states that the average

Ebola case fatality rate is around 50% case fatality

rates have varied from 25 per cent to 90 per cent in past

outbreaks. People diagnosed with Ebola receive

supportive care and treatment for complications.

“During the Ebola outbreak, we captured 253 Ebola

viruses during the treatment of a comatose doctor

with multiple organ failure. While treating, the

patient's viral load reduced from approximately

400,000 copies/ml to approximately 1000 copies/ml.

The patient made a full recovery and was able to

return home to his wife and children”.

Validating viruses

In health compromised individuals, latent viruses that

normally don't pose a threat, can become reactivated

and overwhelm the immune system.

“We have validated three of the most comment latent

viruses, which include Cytomegliovirus, Epstein-Barr

and Herpes Simplex Virus. Most of the viruses

validated by Aethlon medical are not curable with

traditional drug or vaccine therapies.

“We measure the capture of such viruses during

treatment as a means to verify that our device

achieved the goal of its label indication, which is the

single-use removal of viral pathogens from blood.

Instead of c laiming to cure, we deploy our

Hemopurifier to augment the patient's immune

system or to improve the benefit or other therapies

should they exist.”

Future goals

At this point, Aethlon's main focus will be directed

toward establ ishing large-scale product ion

capabilities of Hemopurifier.

“As a company, we are also interested in the

possibility of eliminating tumor-derived exosomes

from the circulatory system of cancer patients. This

would represent a significant unmet need in

healthcare are tumor-derived suppress the immune

system of cancer patients and play a role in the spread

of metastasis, which contributes to upwards of 90 per

cent of cancer deaths.

“I can conclude that we are interested providing our

Hemopurifier to countries that wish to protect their

citizens from emerging bio-terror and pandemic

threats that are not treatable with traditional drug

therapies,” concludes James.

Aethlon Medical

Aethlon Medical combats infectious disease and

cancer with Immunotherapeutic Technologies. To

augment the body's natural immune defenses, the

Aethlon Hemopurifier® eliminates life-threatening

disease targets that are often shielded from the

immune system and not well addressed by traditional

drug therapies. The technology captures circulating

viruses, bacterial toxins and cancer promoting

exosomes through affinity attachment to a unique

structure that cloaks these targets from immune

detection. At present, the Hemopurifier® is being

advanced under an FDA approved clinical study.

Feature

The Hemopurifier is a single-use

disposable cartridge that Aethlon

designed for use within the

established infrastructure of dialysis

machines and other blood circulatory

instruments already located in

hospitals and clinical worldwide

James A. Joyce, Chairman and CEO Aethlon Medical

14

Feature

ltrasonography (US) is an integral modality in Uhealthcare in general but even more so in emergency care. This technology has become a

pivotal part of the care that is administered to patients who are admitted for emergency care. Over the past few decades there has been an exponential increase in the use of ultrasonography which has become the standard of care for an emergency patient. Unfortunately, the awareness of this modality is not as pronounced in healthcare culture as it should be and therefore this

article will seek to shed some light on the importance of ultrasound in acute medicine.

Ultrasonography is a diagnostic imaging technique that is primarily used to visualize viscera and other internal structures in the body. It works based on the principles of physics by utilizing the properties of sound. Sound waves with frequencies greater than those audible to the human ear, appropriately named ultrasonic waves, are sent as pulses through a transducer into the body which are then reflected back as echoes of varying

Exponential growth in Ultrasonography in emergency medicineDescribed as a diagnostic imaging technique primarily used to visualize viscera & other internal structures in the body, ultrasonography utilizes the properties of sound

degrees depending on the physical properties of the tissue they reflect off of.

These echoes are then recorded and displayed as an image which is used by the operator to further his clinical impression or strategy. The primary advantages that make ultrasound superior to other imaging modalities is its ability to provide the healthcare professional images in real-time without the use of

ionising radiation which is a considerable disadvantage encountered with other imaging modalities.

Invaluable utility in healthcare

Ultrasound applications offer advanced diagnostic and therapeutic tools to facilitate patient care with minimal requirements in capital, space, energy or training hence making it an invaluable utility in acute medical care. It is also the most cost effective imaging modality available for recurrent use. Ultrasonography is a science that is taught at every standard of medical education in one form or another displaying the importance of understanding the dynamics of ultrasonography and the value it adds to a healthcare professional upon acquiring the skill of operating the probe and interpreting the sonograms.

Ultrasound imaging and information systems are increasing in integration and sophistication providing more versatility and mobility in use of the modality. The hardware and equipment required to use ultrasound is diminishing in size as we progress into the future with instruments now available the size of the smartphone with the added benefit of wireless connectivity which integrates the device to the Electronic Medical Records (EMR) and Picture Archive Communications System (PACS). The practice of using ultrasound in medical practice is growing and has found its place in the world of emergency medicine.

Emergency Ultrasound (EUS) is used to evaluate acute and critical medical conditions and it is utilized for numerous medical reasons like diagnosis, resuscitation of the acutely ill or injured patients, guidance of medical interventional procedures, monitoring of specific pathological conditions and as an adjunct to therapy. EUS examinations are performed and interpreted by emergency physicians in both, in-hospital and out-hospital settings. EUS is interchangeably also used instead of terms like point of care or focused ultrasound. EUS is a distinct entity from physical examination that provides the physician with anatomical & physiological data that is otherwise not acquired through methods used in a physical examination like inspection, palpation

or auscultation.

EUS is classified into the following functional clinical categories:

• Resuscitative

• Diagnostic

• Sign and symptom based

• Procedural guidance

• Therapeutic and monitoring

There are 12 functional US applications where it is applicable to use the modality efficiently:

• Trauma

• Pregnancy

• Cardiac and Hemodynamic assessment

• Abdominal aorta

• Airway

• Biliary

• Urinary tract

• Deep venous thrombosis

• Soft tissue and musculoskeletal

• Ocular

• Bowel

• Procedural

ER physicians are therefore trained and educated in basic ultrasound physics, instrumentation, procedural guidance and Focused Assessment with Sonography in Trauma (FAST). This leads to ultrasound guided procedures which provide safety in performing a wide variety of procedures involving drainage, US guided

15

Feature

Sound waves with frequencies greater than those audible to the human ear, appropriately named ultrasonic waves, are sent as pulses through a transducer into the body which are then reflected back as echoes of varying degrees depending on the physical properties of the tissue they reflect off of

Ultrasound imaging and information systems are increasing in integration and sophistication providing more versatility and mobility in use of the modality. The hardware and equipment required to use ultrasound is also diminishing in size.

nerve block and vascular access which without the existence of US would expose the patient to great risk. Overall these methods not only increase the standards in patient safety but also allow the treatment of pain in patients without the side effects encountered with systemic opiate use.

The existence of EUS in our healthcare system is greatly advantageous but it also serves as an invaluable tool in other subsets of the population for different reasons. The paediatric population of patients benefits greatly from this as they are at a greater risk when it comes to ionising radiation exposure hence US serves as the most appropriate imaging modality. Furthermore, US is used widely in critical care, prehospital settings and in rural and remote areas where access to technology is limited. Its use is also of paramount importance in disaster medicine and when addressing global public health issues.

Evolving spectrum

Training is provided to healthcare professionals and is based on a wide array of principles which are in line with the evolving spectrum of training in cl inical ultrasonography. They are introduced to the skills required in operating the device and applications are taught along with core concepts that are reinforced. In

line with the evolution of both medical education and the advancement of the technology embedded in US devices innovative educational strategies are implemented to provide environments for learning that prepare the practitioner for using the skills acquired in a clinical setting. This is done through problem based scenarios and simulated cases upon which the practitioners practice before implementing their learned skills in the clinical settings whether they be in-hospital or out-of-hospital.

As previously mentioned, the advantages of this imaging modality are immense and improving. Patient safety is the headline, however it also decreases medical mistakes during procedures leading to more patient satisfaction. There is an improved utilization of the depar tmental resources, eliminating invasive procedures which are not cost friendly. Overall, utilization of the US modality leads to improved clinical decision making and therefore a better outcome in patient care.

The future of EUS has already been given birth to as wireless transducers and handheld systems are readily available at many healthcare institutions. This will not only allow an expanded availability of US to clinical settings at affordable rates. Telesonography is another innovation that allows for graphical data to be transmitted from remote locations to centers that can offer consultations and treatment strategies over a distance. An increased number of multi-centre studies will allow the emergence of higher levels of evidence which would lead to the development of more guidelines that can better direct acute medical care whilst simultaneously promoting the use of US in medicine.

Feature

16

In line with the evolution of both medical education and the advancement of the technology embedded in US devices innovative educational strategies are implemented to provide environments for learning that prepare the practitioner for using the skills acquired in a clinical setting

18

Technology

New Mammography device puts pressure control in patient's hands

E Healthcare won FDA clearance for the first Gmammography system, the Senographe

Pristina Dueta, that lets women undergoing an

exam to control how much the device compresses the

breasts. As the woman is prepared for the exam, she is

handed a small remote control that has a plus and minus

buttons on it. The breast is then positioned by the

technologist between the compression plates and from

then on the patient has control in terms of how much

compression she's willing to take, Medgadget reported

recently.

While compression is still necessary to achieve proper

imaging, patients that have undergone examination

using the Senographe Pristina Dueta report a more

comfortable experience and the clinicians noted

considerably more relaxed patients. Reduced stress in

the examination room can help lead to better images, as

the patient cooperates better and moves less. This can

therefore lead to earlier detection of cancer, earlier

treatment, and improved final outcomes.

GE Healthcare hopes that by improving the experience

more women will be interested in regular mammography

screenings, improving the overall rate of treatment and

lowering the burden of breast cancer.

“This is a new age in breast imaging,” said Dr. Kathy

Schilling, Medical Director of Christine E. Lynn Women's

Health & Wellness Center at the Boca Raton Regional

Hospital.

“Patients who used the remote control said the exam

was more comfortable and they were visibly more

relaxed. Any breast radiologist knows that when

patients are relaxed, we are able to get better images

and better images lead to a more confident diagnosis,''

the radiologist who conducted a clinical review of the

new device said.

The first-ever remote control device for a mammogram

that allows women to adjust their own breast compression

GE Healthcare recently received FDA clearance for 'Senographe Pristina Dueta' that

allows women undergoing an exam to control the rate of compression

''My hope is that increasing comfort during the exam and

giving patients the option of working with the

technologist to set their own compression will increase

compliance, enable early detection and improve

outcomes,” he added.

The best chance of early detection of breast cancer is a

mammogram. Evidence shows that finding breast cancer

early reduces a woman's risk of dying from the disease by

25 to 30 per cent or more. But for many women, the

number one reason they don´t schedule a mammogram

is because of the fear and anxiety from the potential

result and exam discomfort. That's why a team of female

engineers and designers in Paris came together to design

the new mammography technology.

Inside GE Healthcare's imaging technology center in the

town of Buc, located just outside of Paris, Industrial

Designer Aurelie Boudier brought a team of women

together to bring their unique insights as patients to

answer one question: how do we design a more

comfortable mammogram? Their vision would eventually

turn into a new mammography system unlike any others,

one designed specifically with comfort in mind.

“My challenge was how to totally change the perception

of mammography, especially for the patient, and increase

compliance,” Boudier says.

The result is a completely redesigned mammography

system, Senographe Pristina,that now features an option

to use a first-in-industry patient-assisted compression

remote control to enable the patient, with the help of a

technologist, to set the compression that feels right for

her.

The handheld wireless remote control, called Pristina

Dueta, allows patients to adjust the compression force

after breast positioning. The technologist then guides

the patient while she operates the remote control to

adjust compression until she reaches an adequate

compression level.

“The design strives to minimize women's perceived pain

and discomfort by giving them an active role in the

application of compression,” Boudier says.

In a patient satisfaction study conducted with 160

patients in two sites in Europe, when a patient

experienced a Senographe Pristina exam coupled with

Pristina Dueta, 79 per cent of the patients who used the

patient-assisted compression device found it improved

the comfort of their exam, and 54 per cent found it led to

less anxiety.

Design for Comfort

The system features other design enhancements to make

the exam more comfortable.

“We know that compression can be painful,” Boudier

says. “Senographe Pristina is more comfortable and the

design helps improve patient comfort during screening.

Because the imaging detector is thinner with rounded

corners, patients say that it's more comfortable because

there's less coming in contact with their bare skin.”

19

Technology

In a patient satisfaction study conducted with 160 patients in two sites in Europe, when a patient experienced a Senographe Pristina exam coupled with Pristina Dueta, 79 per cent of the patients who used the patient-assisted compression device found it improved the comfort of their exam, and 54 per cent found it led to less anxiety.

GE Healthcare gets

FDA approval for

Senographe Pristina

Dueta, the first

mammography

device that

addresses pain &

anxiety & lets the

woman to choose

the compression of

breasts.

20

Technology

The system's design also changes the way a patient is

positioned. Instead of women projecting their stress on

handles by grabbing them too firmly, which tenses

pectoral muscles and has an impact on image quality,

they can lean comfortably on the armrests, relaxing the

muscles to simplify positioning, compression and

image acquisition.

When the patient is more relaxed, technologists can

focus on precise positioning, potentially making the

exam easier and faster. This reconsidered philosophy of

patient positioning is a totally different approach,

according to Boudier. These new compression

techniques and positioning options are a powerful

combination in terms of patient perception and patient

comfort.

Feedback

With empathy at the center of this product, part of the design process was working closely with patients, technologists and radiologists from Gustave Roussy Cancer Center in Paris, one of the largest cancer treatment centers in Europe. These key stakeholders gave GE Healthcare critical input to ensure the system addressed clinicians' and patients' concerns.

Senographe Pristina also incorporates calming colors and smooth shapes again to help reduce patient anxiety and make the mammogram a more positive experience. Boudier says users are optimistic that the system will help inspire women to come back for screening every two years. “We've gotten very good feedback,” she says. “Physicians say patients are pleased with the machine.”

More than mammography

Senographe Pristina is part of GE Healthcare's commitment to the SensorySuite, which simultaneously stimulates at least three of a woman's senses – scent, sight and sound – and improves the experience globally in an immersive strategy to help reduce the perceived discomfort, pain and anxiety of a mammogram.

Boudier says this “innovative design approach” was a deliberate design choice. “We really considered not only clinicians, but every user – the technologist and the patient,” she says. “I know that our team did our job if more women are going for their annual mammograms and aren't scared to walk into the room and do the exam. It's such an important part of maintaining a healthy life and I want it to be a less painful experience for women around the world.”

“We really considered not only clinicians, but every user – the technologist and the patient,” she says. “I know that our team did our job if more women are going for their annual mammograms and aren't scared to walk into the room and do the exam. It's such an important part of maintaining a healthy life and I want it to be a less painful experience for women around the world.”

Health Destination

Consumer-driven healthcare systemhealthcare system

Consumer-driven Zürich and Geneva have each been ranked top cities in the world in terms of quality of life, with the former ranked second globally, according to Mercer.

22

witzerland is a landlocked country geogra-Sphically divided between the Alps, the Swiss

Plateau and the Jura, spanning an area of 41,285

km2. While the Alps occupy the greater part of the

territory, the Swiss population of approximately eight

million people is concentrated mostly on the plateau,

where the largest cities are to be found: among them are

the two global cities and economic centres Zürich and

Geneva.

“Switzerland is a very small country with a small

population, and it actually has very few natural

resources,” Saadia Zahidi, Senior Director of the World

Economic Forum.

“The biggest resource it does have is people, and that's

what it's been investing in for quite some time. It's led to

an economy that is competitive, highly innovative, and

has adopted technology fast.”

Switzerland is one of the most developed countries in

the world, with the highest nominal wealth per adult

and the eighth-highest per capita gross domestic

product according to the IMF. Switzerland ranks at or

near the top globally in several metrics of national

performance, including government transparency, civil

liberties, quality of life, economic competitiveness, and

human development. Zürich and Geneva have each

been ranked among the top cities in the world in terms of

quality of life, with the former ranked second globally,

according to Mercer.

“Countries that invest in human capital end up getting

returns in terms of economic growth,” says Zahidi. “And

then countries that have that economic growth are able

to reinvest further in human capital. So you have this

virtuous cycle that's established.”

Human capital is a function of four pillars: health and

wellness, education, work and employment, and what

WEF calls an “enabling environment,” which includes

factors like legal framework and infrastructure that

allow for returns on human capital. Switzerland topped

the index by generating high scores across the four

pillars, coming in first in the health and wellness and

workforce and employment categories, second for

enabling environment and fourth in education — which

goes a long way in explaining the success of the Swiss

economy.

23

Health Destination

“The Swiss have universal coverage, the healthiest population in the Western Hemisphere, and a government that spends a mere 2.7%of GDP on health care: about a third of what ours spends,” writes Forbes's Avik Roy. “The Swiss system isn 't per fectly transposable onto the United States, but it is vastly superior. And the Swiss do it with a top federal income tax rate of only 11.5 %, compared to 35 % in the US of A.”

Healthcare funding

Switzerland's healthcare system derives a significant portion of funding from mandatory Swiss health insurance premiums (averaging around EUR 450 per month) and out-of-pocket payments, meaning there is no free healthcare in Switzerland. In line with the high cost of living in Switzerland, Swiss health insurance equals around 10 percent of the average Swiss salary.

Basic healthcare facts

1 - Switzerland spends the highest percentage of GDP on healthcare (around 11.4 percent) compared to all EU countries.

2 - Basic health insurance is compulsory in Switzerland, although you are free to choose your own Swiss health insurance company.

3 - In the EU's latest statistics, Switzerland was the only country compared to the EU to total more than EUR 4,500 per inhabitant on healthcare expenditure.

4 - The OECD reports that Switzerland's healthcare expenditure is the second highest among all OECD countries (along with the Netherlands), with the US in

first place, totaling almost double the OECD average spent per inhabitant.

5 - Out-of-pocket spending, however, accounted for just over a quarter of all health spending, which is relatively high compared to the OECD average of 19.5 percent and neighboring countries such as Austria (17 percent), Germany (13 percent) and France (7 percent).

6 - Healthcare is largely organized by Switzerland's individual communes. The health ministers from all cantons form the Swiss Conference of the Cantonal Ministers of Public Health (GDK), which aims to promote cooperation & implement common policies between cantons.

Top healthcare system

When it comes to health and wellness — taking into

account longevity, infant mortality, and the general

state of physical and mental health of the population,

and quality of healthcare — the Index places the Swiss

in the number-one spot. The Swiss have the lowest

government spending on health care in the developed

world — and some of the healthiest citizens.

Swiss healthcare combines public, subsidized private

and totally private healthcare systems to create an

extensive network of highly qualified doctors (many of

them from elsewhere in the EU) and Swiss hospitals, the

best-equipped medical facilities and no waiting lists –

but it all comes at a price.

It is the only developed country with a long-standing

consumer-driven health care system, providing broad

evidence and important lessons about its efficacy.

Unlike most of its European neighbors, it is a haven of

quiet in a roiling sea. Its consumer-driven health care

system mirrors the country's traditional independence,

as citizens may freely choose plans, and its solidarity, as

it requires everyone to purchase health insurance and

subsidizes the needy. But it more closely mirrors its

neighbors' centrally controlled health care systems in

the constraints placed on insurers and providers.

“The Swiss have universal coverage, the healthiest population in the Western Hemisphere, and a government that spends a mere 2.7 percent of GDP on health care: about a third of what ours spends,” writes Forbes's Avik Roy. “The Swiss system isn't perfectly transposable onto the United States, but it is vastly superior. And the Swiss do it with a top federal income tax rate of only 11.5 percent, compared to 35 percent in the US of A.”

He further stated that he is positive about the key directions of the strategic partnership with Hoffman-La Roche, which will focus on formulating a national index for cancer deaths per 100,000 of the population. The Ministry will also work on the creation of a national committee in cooperation with other health authorities to develop a plan to control the growth of cancer & reduce deaths by 25 percent by 2021, based on the 2013 baseline.

Hoffman-La Roche's Sabra commented: "We are confident that this strategic partnership with the Ministry of Health and Prevention in the UAE will support the effective implementation of this noble initiative. We will build on our role in this partnership to provide the necessary expertise to assess the current situation and support the development of a national program for the fight against cancer. We thank the Ministry for this partnership and we are committed to meet our key targets.”

Under the MoU, Hoffman-La Roche will provide tools and statistics for strategic analysis and expertise in the fight against cancer and prepare a road map to achieve the target index. It will also conduct a situational analysis, track diagnosis and forms of therapy and support research studies on how to control cancer. The firm will support workshops and educational activities, training and awareness campaigns, as well as other MOHAP innovative activities related to the initiative as well.

MoU signing

The Ministry of Health and Prevention (MOHAP) has announced that it recently signed a Memorandum of Understanding (MoU) with Swiss multinational pharmaceutical firm Hoffman-La Roche with specialties in treating tumors, among others. The agreement aims to address the growing number of cancer cases in the UAE and reduce death rates by 25 per cent by the end of 2021 as part of the Ministry's efforts to find innovative cancer treatments and ensure that health services are on par with international best practices.

Dr. Youssif Al Serkal, Assistant Undersecretary for the Hospitals Sector at MOHAP, and Abed Al Rahman Sabra, Country Manager of Hoffman-La Roche, signed the MoU at the MOHAP headquarters in the presence of Dr. Muna Al Kuwari, Director of Specialized Healthcare at the Ministry, and a delegate from the pharmaceutical firm.

Dr. Al Serkal said that cancer incidences in the UAE are spreading at a rate lower than those of Western countries, noting that the Ministry of Health continues to expand its partnerships with various organizations to bring in quality healthcare for cancer patients as part of its strategy to improve health facilities as well as its systems and ensure easy access in accordance with international standards. These efforts are in line with the UAE's goal to become one of the best countries in the world in providing quality healthcare with key targets embodied in the National Agenda under the UAE Vision 2021.

24

Health Destination

Dr. Youssif Al Serkal, Assistant

Undersecretary for the Hospitals

Sector at MOHAP, and Abed Al

Rahman Sabra, Country Manager of

Hoffman-La Roche, signed the MoU at

the MOHAP headquarters in the

presence of Dr. Muna Al Kuwari,

Director of Specialized Healthcare at

the Ministry, and a delegate from the

pharmaceutical firm.

26

News & Updates

For the second year in a row, Cleveland Clinic is ranked the No. 2 hospital in the United States by US News & World Report, retaining its position as the No. 1 hospital for cardiology and heart surgery for the 23rd successive year, a statement released by its branch in Abu Dhabi said recently.

“I am incredibly proud of this organization and everyone who works here,” said Toby Cosgrove, MD, Cleveland Clinic president and CEO. “These rankings are a reflection of our caregivers' unwavering commitment to providing the very best care to the patients we are privileged to serve.”

Cleveland Clinic Abu Dhabi, which opened in 2015, is a unique and unparalleled extension of US-based Cleveland Clinic's model of care, designed to address a range of complex and critical care requirements in support of the region's specific healthcare needs. The hospital provides patients direct access to the world's best healthcare providers with more than 30 medical and surgical specialties represented through 13 institutes.

Cleveland Clinic Abu Dhabi's Heart and Vascular Institute was the first in the Middle East to introduce transcatheter aortic valve replacement as an alternative to traditional open-heart valve replacement surgery .It offers a wide spectrum of services, from diagnostic to cutting-edge treatments, such as hybrid coronary revascularization, and minimally invasive and robotic cardiac surgery.

Tomislav Mihaljevic, CEO of Cleveland Clinic in Abu Dhabi said: “We are proud to play a significant role in the expanding international story of Cleveland Clinic. Every day, our dedicated physicians and nurses deliver Cleveland Clinic's commitment to excellence in complex and critical heart care to the people of the Middle East.”

In compiling its rankings, US News studied objective data, such as risk-adjusted survival, readmission rates, volume, patient experience, patient safety, quality of nursing care and other care-related indicators.

Rare disease diagnosed

Meanwhile, physicians at Cleveland Clinic in Abu Dhabi have successfully diagnosed and begun treatment on a patient with a rare immunodeficiency disorder, Wam reported.

The patient, a 27-year-old UAE national, had been suffering from Hereditary Angioedema (HAE), a

potentially life-threatening, inherited blood disorder.

Suffering from chronic severe abdominal pain and swelling in his hands and feet over a five-year period, the patient, Ibrahim Yaqoub Ibrahim Alali, sought help from a number of hospitals before being referred to Cleveland Clinic Abu Dhabi's Medical Subspecialties Institute.

Dr. Mohamed Abuzakouk said: “This patient is the first UAE national to be diagnosed with this rare immunodeficiency at this hospital. The patient had previously visited several hospitals and undergone a m u l t i t u d e o f c o m p l i c a t e d and sometimes i n v a s i v e medical tests tha t had not h e l p e d determine his condition. He was brought to C l e v e l a n d C l i n i c A b u D h a b i ' s e m e r g e n c y d e p a r t m e n t during one of his episodes of abdominal pain and subsequently underwent extensive immunological assessment and was successfully diagnosed before commencing the appropriate treatment.''

There are two types of HAE, with type one is more common affecting between 80 per cent and 85 per cent of patients. Type two only occurs in the remaining 20 per cent.

''Our patient had type two HAE, the rare form of this condition. Symptoms of the rare disorder include swelling in the face, larynx and elsewhere alongside severe, colicky abdominal pain. However, when properly treated patients can generally live long, symptom-free lives, the doctor treating the patient said.

The case highlights the value of Cleveland Clinic Abu Dhabi's multidisciplinary approach, which brings together experts from across a range of fields to tackle complex cases. The hospital's Medical Subspecialties Institute covers nine specialties and deploys advanced laboratory testing facilities to cover a broad spectrum of medical needs including rare immunological disorders.

Cleveland Clinic retains top position for heart care

Dr. Mohamed Abuzakouk

27

News & Updates

The Health Education Department of the Supreme Council for Family Affairs in the Emirate of Sharjah launched its fourth annual health and tourism campaign and the world's first online health and tourism campaign after three successful years of achievement in enhancing active lifestyle as well as promoting touristic areas in the city. The campaign will run until September 16 and is supported by several health organizations in the emirate, including the Friends for Diabetes, Friends of Arthritis Patients, Friends of Kidney Patients, Friends of Cancer Patients, Breastfeeding Friends and the Health Education Department.

Details about the campaign were announced during a press conference attended by Iman Rashid Saif, Director of Health Education, Department of the Supreme Council for Family Affairs, Sharjah Government Media Bureau, Sharjah Commerce and Tourism Development Authority and its sponsors.

Saif said the health and tourism campaign is one of the most important educational and awareness campaigns, which was launched to raise health awareness among citizens and residents as well as highlighting the touristic areas in the emirate. Seven tourist sites including Heart of Sharjah, Central Market, Al Majaz, Al Qasba, Al Majaz Theater and Flag Island have been chosen as the best locations for lovers of walking.

Saif also emphasized the importance of community participation in the campaign's fourth year programs

and activities, which aims to highlight the role of walking in improving health, preventing disease and encouraging the public to take a positive outlook. The campaign offers free medical check-ups and tests.

This year's campaign will be held under the theme 'Lets walk' to enhance the culture of walking as the lack of activity increases the risk of serious and chronic illnesses by 30 per cent meanwhile walking regularly helps to decrease death rate by 50 per cent. The 'Lets Walk' initiative is part of a wider health and tourism awareness campaign launched this year by Sharjah's local government in cooperation with the Sharjah Commerce and Tourism Development Authority and a number of local hospitals and organizations.

Sharjah launches health awareness campaign

Treating insomnia can ease depression and paranoiaTreating young people who suffer from insomnia by using online cognitive behavioural therapy (CBT) could reduce debilitating mental health problems such as anxiety and depression, researchers said according to Reuters report released in London.

In a large trial published in The Lancet Psychiatry journal, researchers at Oxford University's Sleep and Circadian Neuroscience Institute also found that successfully treating sleep disruption eased psychotic symptoms such as hallucinations and paranoia.

"Sleep problems are very common in people with mental health disorders, but for too long insomnia has been trivialised as merely a symptom, rather than a cause, of psychological difficulties," said Daniel Freeman, a professor of clinical psychology who led the work.

"This study turns that old idea on its head, showing that insomnia may actually be a contributory cause of mental health problems," he said.

The research involved 3,755 university students from across Britain who were randomised into two groups. One group had six sessions of online CBT, each lasting about 20 minutes, and delivered via a digital programme called Sleepio. The others had access to standard treatments but no CBT.

Freeman's team monitored participants' mental health with a series of online questionnaires at zero, three, 10 and 22 weeks from the start of treatment. The researchers found that those who had the CBT sleep treatment

reduced their insomnia significantly as well as showing small but sustained reductions in paranoia and hallucinatory experiences. The CBT also led to improvements in depression, anxiety, nightmares, psychological well-being & daytime work & home functioning.

Andrew Welchman, head of neuroscience and mental health at the Wellcome Trust health charity which helped fund the research, said the results suggested improving sleep may provide a promising route into early treatment to improve mental health.

Freeman added: "A good night's sleep really can make a difference to people's psychological health. Helping people get better sleep could be an important first step in tackling many psychological and emotional problems."

NMC to manage Emirates Healthcare assets

NMC Health, an integrated private healthcare provider in the GCC region, has signed a new operations and management contract with Emirates Healthcare, owned by an investment group based in Abu Dhabi. According to contract NMC Health will manage the healthcare assets of the investment group, comprising three brands.

* Emirates Hospitals and Clinics provide General medical services across six emirates in the UAE

* CosmeSurge provides cosmetic medical services in the UAE and the United Kingdom

* Emirates Rehab and Homecare Services provides home nursing, rehabilitation, therapeutic care and home-based care and operates in the UAE, Slovakia and Oman

Emirates Healthcare is a subsidiary of KBBO group. ''The reputation of NMC has prompted us to sign the contract for managing our healthcare assets. We look forward to the future of these assets with great anticipation,” said Yazen Abu Gulal, Chairman of Emirates healthcare.

“The reputation of NMC Health informed our decision to sign over the management of Emirates Hospitals and Clinics, CosmeSurge and Emirates Rehab & Homecare Services. With this signing, we look forward to the future of these assets with great anticipation,” added Yazen Abu Gulal, CEO of KBBO Group and Emirates Hospital Chairman.

NMC Health is now managing multiple private and public sector health care facilities across varied geographies, with total annual revenues from operations and management verticals set to reach $19 million

(Dh69.7 million), the company said in a statement.

The company's contract to manage the 205-bed Sheikh Khalifa General Hospital in Umm Al Quwain was extended for a further five-years. The original contract was the first ever awarded by a government department to a local UAE business to manage a large government healthcare facility. It demonstrated the confidence in NMC's signif icant healthcare experience and capabilities, the company said.

Revenues rise

Meanwhile, NMC Health has reported a revenue increase of 34 per cent to $775.2 million during the first half of 2017, compared to first half of 2016 which amounted to $578.3 million.

NMC Health produced strong performance in H1, 2017 with good progress seen across all parts of the group. Its newly opened facilities continue to ramp-up well and the group's acquired businesses are benefitting from both improved performance and the commencement of planned integration projects, the company said.

“Our long-term growth strategy, predicated on capacity and then capability focussed growth, continues to accelerate our expansion into more complex medical, and thus higher value added, specialty healthcare segments. The subsequent establishment of new strategic multi-brand verticals is enabling us to unlock synergies within the enlarged group, delivering significantly improved growth for the NMC group despite the continuing more moderate macro environment in our primary market of the UAE,” it said.

28

News & Updates

UAE's Julphar names Laurent de Chazeaux as acting CFOJulphar Gulf Pharmaceutical Industries announced the appointment of the company's Associate Director of Finance, Laurent de Chazeaux, as Acting Chief Financial Officer, effective immediately. Laurent replaces Jerome Carle, who has been appointed GM of Julphar.

Julphar's Chairman, Sheikh Faisal Bin Saqr Al Qasimi, said, "Laurent is an established financial executive with extensive background overseeing finance organisations. With him leading the finance team, I am confident that we will be well-positioned to enter the next phase of our strategy execution."

"I am much honoured to have been appointed to this role," said Laurent de Chazeaux. "I will work closely with the executive team and focus on driving performance to help the company achieve its next stages of growth." As

Acting CFO of Julphar, de Chazeaux will be responsible for leading Julphar's finance department and keeping accurate financial records. He will be in charge of the administrative and risk management operations and will develop financial strategies in line with the company's objectives. He will report to the company's recently appointed General Manager, Jerome Carle.

Over the last 20 years, de Chazeaux has worked in a number of senior finance roles in the pharmaceutical industry & investment banking. He spent several years working for Cowen, where he was in charge of analysing performances of midsize European pharmaceutical companies & before joining Julphar as Associate Director Finance in June 2017, he worked at Sanofi & as Finance Director at AstraZeneca.

Fast food chain cut global antibiotic use in chickens

29

McDonald's Corp said that it would begin curbing the use of the high value human antibiotics in its global chicken supply in 2018, as the fast-food giant joins a broad effort to battle dangerous superbugs. McDonald's, in a policy statement, said it is working on antibiotic plans for other meats, dairy cows and laying hens.

McDonald's is requiring suppliers of chicken meat to begin phasing out the use of antibiotics defined by the World Health Organization as "highest priority critically important antimicrobials" (HPCIA) to human medicine.

Public health and consumer groups applauded the move, which is not as strict as the company's policy for the United States, where already for a year suppliers have provided the chain with chickens raised without antibiotics deemed important to human health.

In January 2018, HPCIAs will be gone from McDonald's chickens in Brazil, Canada, Japan, South Korea, the United States and Europe. Only in Europe the company will make an exception for Colistin, a last resort antibiotic. By the end of 2019, suppliers in Australia and Russia will stop using HPCIAs and European suppliers plan to remove Colistin. Suppliers in all other markets will comply by January 2027.

"Our goal is to have this policy implemented before this date," McDonald's said in its posted antibiotic policy update. McDonald's told a group of consumer and environmental organizations on Aug. 17 that 74 percent of its global chicken sales will conform to this policy as of January 2018, Consumers Union, the policy division of Consumer Reports, said in a statement. Consumers Union also said the company told the group that it hopes to have a timeline soon for reducing medically important antibiotics from its beef supply. McDonald's declined comment on sales figures and its plans for beef.

More than 70 percent of medically important antibiotics in the United States are sold for livestock use. Scientists have warned routine use of antibiotics to promote growth and prevent illness in healthy farms animals contributes to the rise of dangerous antibiotic-resistant superbug infections, which kill at least 23,000 Americans each year and pose a significant threat to global health.

"If fully implemented, (the plans) could be a total game changer that could transform the marketplace given the company's massive buying power," Jean Halloran, Consumers Union's director of food policy initiatives, said in a statement.

News & Updates

Safe transportation and disposal of hazardous and medical wastes urgedDubai Municipality, DM, has urged companies working in the field of production and transportation of hazardous and medical waste to take extra care in the safe disposal of the waste.

Abdulmajeed Sifai, Director of the Waste Management Department, said that DM endeavours to achieve environmental sustainabil ity and suppor t al l environmental policy focuses included in the UAE Vision 2021, launched by Vice President, Prime Minister and Ruler of Dubai, His Highness Sheikh Mohammed bin Rashid Al Maktoum, aimed at raising the quality of life in the country by building a diversified economy that preserves the environment and achieves sustainable development.

He was speaking at a customer forum of the companies working in the field of transportation and production of hazardous and medical waste. The forum, aimed at creating excellent environmental partnerships with the private sector and providing quality services that satisfy the aspirations of all customers, was attended by more than 100 representatives of these companies.

Sifai said that the forum was a real platform and a direct window to broaden the horizons of serious dialogue and

face-to-face interaction with customers to hear their constructive comments and identify their needs closely in order to reach the highest levels of public satisfaction by providing the best services in accordance with internationally recognised standards.

The forum included presentations by the hazardous waste treatment engineers on the requirements for the transfer of medical and hazardous waste and the best way to apply for disposal services.

There were also presentations on the development projects of the hazardous and medical waste treatment complex in Jebel Ali, and the requirements of applying the highest standards of occupational health and safety.

30

Good practice in OSH can help make businesses productive, competitive and sustainable, as well as reduce healthcare costs and other societal burdens. However, the costs of poor OSH are high for individuals, businesses and society. Through the costs and benefits project, EU-OSHA has taken steps to identify and evaluate the data that is available in the EU and worldwide to develop accurate and up-to-date estimates of the costs of work-related diseases and injuries.

According to further findings, work-related illnesses account for 86 per cent of all deaths related to work worldwide, and 98 percent of those in the EU. An estimated 123.3 million DALY (disability-adjusted life years) are lost globally, with 7.1 million in the EU alone, as a result of work-related injury and illness. Of these, 67.8 million (3.4 million in the EU) are accounted for by fatalities and 55.5 million (3.7 million in the EU) by disability.

In most European countries, work-related cancer accounts for the majority of costs (EUR119.5 billion or 0.81 percent of the EU's GDP), with musculoskeletal disorders being the second largest contributor.

Worldwide work-related injury and illness result in the loss of 3.9 percent of GDP, at an annual cost of roughly EUR2,680 billion, according to new global estimates presented by the European Agency for Safety and Health at Work, EU-OSHA, together with the International Labour Organisation, ILO, at the XXI World Congress on Safety and Health at Work, being held in Singapore on 3-6 September.

The estimates are findings from a major project on the costs and benefits of occupational safety and health, OSH. The project was carried out by the ILO, the Finnish Ministry of Social Affairs and Health, the Finnish Institute of Occupational Health, FIOH, the WSH Institute in Singapore, the International Commission on Occupational Health, ICOH, and EU-OSHA.

The Director of EU-OSHA, Dr. Christa Sedlatschek, said, "Safe and healthy work is a fundamental human right but these new estimates of the costs of poor or non-existent OSH measures show that the economic case for OSH has never been stronger. Work-related ill-health and injury cost the European Union 3.3 per cent of its GDP. That's EUR476 billion every year, which could be saved with the right occupational safety and health strategies, policies and practices."

“Work-related accidents and injuries cost almost EUR2.7 billion a year”

News & Updates

Conference in Radionuclide Therapy to focus on latest trendsThe Dubai Health Authority, DHA, is organizing the 2nd Emirates International Conference in Radionuclide Therapy and Theransotics, from 15-18 September. The three-day medical event is managed by the Department of Nuclear Medicine and Molecular Imaging at the Dubai Hospital, part of the DHA.

The conference, the first of its kind in the Middle East, will discuss the treatment and diagnosis of cancer using radioactive nuclides. Its participants will include Gulf Cooperation Council, GCC, countries, as well as 10 other countries, including India, Pakistan, Sweden, Iran, Jordan, Iraq, Egypt, Nigeria, and Japan.

Batool Al Baloushi, Conference Chair, stated that the conference will discuss the latest trends and methods in the field of radionuclide therapy and molecular imaging,

as well as the latest relevant research and protocols.

''The conference is unique because of the variety and the number of world-class lectures presented by experts in this field, to obtain the maximum benefits and exchange opinions and experiences,'' she added.

Fifteen international lecturers will participate in the conference and hold interactive sessions on radionuclide therapy for certain types of cancer, such as breast, thyroid and prostate cancers. The lecturers are all nuclear medicine professors from the UAE, Japan, the USA, Germany, Jordan, Kuwait, the Philippines & India.

During the conference, Prof. Jun Hatazawa, President of the Asian Federation of Nuclear Medicine, is to present the latest therapy using boron neutron therapy for cancer & highlight all nuclear medicine events in the region.

31

News & Updates

for the hospital by eliminating the need for medication outsourcing and decreasing pharmacy waste,” Dr Hansen added.

Dr Elias Fadel, the director of the KHUH Oncology Center,

said: "The safety of our patients and staff is paramount,

and selecting Riva helps ensure we achieve that goal."

KHUH has more than 300 beds and nearly 2,000

employees. The hospital offers comprehensive medical,

surgical and diagnostic services in line with updated

international standards. It is also constructing a national

oncology center to provide first‐class cancer care and

research facilities to the citizens of Bahrain.

“The system's advanced technologies will protect our

staff from exposure to hazardous chemotherapy drugs.

Additionally, it will allow for more doses to be prepared

simultaneously while pharmacists and technicians are

performing other activities, which could improve patient

care,” Dr Fadel added.

ARxIUM, developer of pharmacy automation and workflow solutions, said it has successfully delivered its new Riva IV Compounding System to Bahrain-based King Hamad University Hospital (KHUH), a company statement released from Winnipeg in Canada said.

As the only fully automated IV compounding system on the market today, Riva prepares syringes and IV bags in an aseptic ISO Class 5 environment and significantly increases safety and pharmacy workflow.

KHUH selected Riva because it has safely and accurately produced nearly seven million IV doses worldwide. It is being deployed in the KHUH hospital pharmacy. The hospital also chose the system due to its comprehensive record-keeping and reporting capabilities and seamless integration into existing digital networks, it stated.

Riva's proven cost effectiveness was another deciding factor, as it lowers the cost-per-dose of medications by allowing the hospital pharmacy to insource the production of IV medications and process batch doses.

Dr Niels Erik Hansen, president and CEO of ARxIUM, said: "Our new partnership with King Hamad University Hospital is an exciting opportunity to showcase Riva's unmatched IV compounding capabilities in a facility that is a recognized leader in Bahrain."

“The system's safeguards will serve as a substantial differentiator from competing hospitals in the region. In addition, Riva will generate considerable cost-savings

Bahrain hospital gets Riva IV compounding system

IAG Cargo launches constant climate critical product for pharma shipments IAG Cargo has announced Constant Climate shipments are now able to fly under its Critical product, enabling emergency medical shipments to benefit from IAG Cargo's highest priority service. The new enhancement means that shippers sending urgent pharmaceuticals now have access to the non-off loadable status and performance guarantees offered under Critical.

Less than a year since its launch, Critical has already carried over 2000 emergency shipments for businesses across the world. While the range of goods moved has been diverse – from pre-launch consumer electronic devices to formula one tyres to factory down machine parts – all have required the “must fly” status guaranteed by Critical.

Following successful trials of Constant Climate Critical across India, the UK and Europe, IAG Cargo is rolling out this new offering across all 109 Constant Climate enabled stations on its network.

Alan Dorling, Global Head, Pharmaceuticals and Life Sciences commented: “We are proud of the significant investment that we continue to make into our Constant Climate product and the infrastructure that supports it. We were one of the first carriers to offer a dedicated pharmaceutical shipment product and today our teams across the world deliver the highest level of care and expertise when transporting high-value, temperature-sensitive goods.

“The development of Constant Climate Critical means that we are now able to build on our offering by providing vital vaccines and emergency lifesaving medicines with a non-off loadable status. In addition to our highest priority grading, the product continues to safeguard temperature-specific shipment requirements, maintaining the purity, potency and stability of the lifesaving medicines that we carry.”

David Shepherd, Commercial Director at IAG Cargo commented: “Critical has been a real success; demand has come from right across our network and week on week we see both new requests and repeat business. We know that there is a real demand for guaranteed capacity and a must-fly service for urgent pharmaceutical products and it is crucial that we continue to innovate to ensure that we meet our customers' needs.”

It is anticipated that Constant Climate Critical will be popular across key pharmaceutical trade lanes, from manufacturing hubs in India and Europe and into burgeoning pharmaceutical markets such as Latin America. The service offers guaranteed capacity up to the maximum aircraft operating limit, and a dedicated monitoring service through hubs at London Heathrow, Madrid and Dublin. Customers shipping through the carrier's Heathrow and Madrid hubs will also benefit from a dedicated Critical check-in desk, significantly speeding up drop off and collection times.

32

Schiphol Cargo focuses on pharma and e-commerce as volumes grow

successful pilot phase. Milkrun partners have established a programme of sharing transportation: single deliveries from handling agents are delivered to multiple forwarder facilities, reducing CO2 emissions and cutting truck queues.

Pieter-Bas Braam, Chairman of the Milkrun Working Group, said; “I am proud that the Milkrun project has become a fully operational scheme, which is already benefitting the Cargo Community at Schiphol.”

Schiphol's biggest market is Europe, with June 2017 inbound volumes at 11,217 tonnes, up 25 per cent on 2016, and June 2017 outbound figures at 11,450 tonnes, up 41.8 per cent on June 2016 figures. This strong growth is the result of Asian cargo, which transits Baku, Azerbaijan, and Moscow, Russia, to and from the Far East and Amsterdam.

A strong flower trade led to inbound Latin America volumes for January to June 2017 of 59,817 tonnes, up 31.4 per cent on the same period in 2016. Exports for January

to June 2017 were 35,275 tonnes, a 6.3 per cent decrease on January to June 2016.

Inbound Middle East figures for January to June 2017 were 43,557 tonnes, down 4.4 per cent on 2016 figures for the same period, with outbound figures to the region for the first half of the year at 61,973 tonnes, up seven per cent on the same period in 2016, when 57,899 tonnes were recorded.

Cargo volumes at Amsterdam Airport Schiphol grew 8.7 per cent to 866,713 tonnes between January and June 2017, up from 797,069 tonnes during the same period in 2016. Europe's third busiest hub welcomed an additional 153 full freighter flights in the first half of the year, making a total number of 8,954 freight ATMs, and handled a record 148,765 tonnes in June, up 9.8 per cent on June 2016 figures of 135,528 tonnes.

Volumes to the Far East grew to 27,706 tonnes in June 2017, up 15 per cent on June 2016 figures of 24,091 tonnes, with inbound Far East volumes reaching 26,511 tonnes in the same month, up 14.1 per cent on June 2016 figures of 23,230 tonnes. Half-year figures for the Far East were 154,866 tonnes for outbound, up 12.2 per cent on the same period in 2016, with inbound figures at 149,836 tonnes, up 8.3 per cent on the same period in 2016.

“The Schiphol Cargo Community has worked on a series of new initiatives this year, which demonstrate our commitment to delivering safe and efficient cargo products, and our excellent first half-year performance is the result of this collaboration,” said Jonas van Stekelenburg, Head of Cargo, Amsterdam Airport Schiphol.

“We are pleased that our continued focus on developing innovative solutions, such as our Compliance Checker and the Milkrun, for our growing base of e-Commerce and pharma customers has helped to deliver strong growth in the first half of the year.

“Our commitment to quality initiatives, such as the Pharma Gateway Amsterdam programme, has ensured that Schiphol remains one of the fastest growing cargo hubs in Europe.”

Schiphol's new Compliance Checker, launched in May, speeds up cargo flows by detecting data errors and Customs compliance errors in air waybills will help boost e-Commerce flows through the hub.

The Community has also recently secured a one million EUR grant to start developing a Pharma Incursion Alerter, an early warning system for shippers, and a pilot phase for the scheme is currently being planned.

In addition, Air Cargo Netherlands' Milkrun initiative, launched in May 2015, became fully operational last month, without the need of a project manager after a

News & Updates

33

Scientists that genotype using a thermocycler typically

rely on the software accompanying the instrument to

analyze their data.

Data from one thermocycler cannot be uploaded to the

software of a different thermocycler, which prevents the

comparison of data attained on different thermocyclers.

Canon BioMedical has solved this problem by providing

free, web-based software capable of analyzing data

from different thermocyclers and well plate formats.

The Novallele HRM Analyzer provides an intuitive and

easy-to-use graphical interface with comprehensive

algorithms capable of analyzing high-resolution

melting (HRM) data from different thermocyclers.

PCR followed by HRM is a fast, reliable, and cost-

effective method for DNA genotyping. The Novallele

HRM Analyzer complements the Novallele genotyping

assays, in conjunction with the Novallele Controls Sets,

to seamlessly analyze HRM data. The software does not

require download or installation.

“Scientists often have many different types of

thermocyclers in their labs,” states Akiko Tanaka, CEO

of Canon BioMedical. “We developed the Novallele

HRM Analyzer so researchers could analyze their HRM

data using one tool. The software adds to our goal of

offering a complete genotyping solution.”

The free Novallele HRM Analyzer is available at

www.canon-biomedical.com. Canon BioMedical, a

wholly owned subsidiary of Canon U.S.A., Inc., is

focused on empowering the biomedical research and

healthcare communities by developing, manufacturing,

and marketing innovative technologies and solutions.

The technologies and solutions developed will help

enable clinicians and scientists to improve our health

and advance science.

Canon BioMedical launches Novallele™ HRM Analyzer

Dedicated Cryo-DualBeam System automates preparation of frozen, biological samples

Product Update

The new Thermo Scientific Aquilos is the first

c o m m e r c i a l C r y o - D u a l B e a m ( f o c u s e d i o n

beam/scanning electron microscope) system dedicated

to the preparation of frozen, thin lamella samples from

biological specimens for high-resolution tomographic

imaging in a cryo-transmission electron microscope

(cryo-TEM).

"The Aquilos completes our cryo-electron tomography

workflow, allowing customers to reliably create the

samples with precisely-controlled thickness with

minimal investment in time and effort," said Peter

Fruhstorfer, vice president and general manager, life

sciences, Thermo Fisher Scientific.

Elizabeth Villa, assistant professor of Biophysics,

University of California San Diego, has been using the

Aquilos cryo-DualBeam in her work on macromolecular

complexes, "Cryo-electron tomography's ability to

visualize structures in their native context allows

researchers to observe functional relationships and

interactions with other components in the cellular

environment," said Dr. Villa. "This technique promises to

become an important tool for scientists seeking a better

understanding of living systems at the molecular level."

Electron tomography computes a three-dimensional

(3D) model of a single molecular structure in its native,

fully functional context by combining multiple images

from different perspectives, much like a medical X-ray

CT (computed tomography) scan. It is a powerful

complement to single particle analysis (SPA), which can

provide near-atomic scale resolution but requires a

large collection of isolated identical particles. Together,

these techniques can provide biologists with a more

complete picture of a protein's structure and function.

34

Product Update

obtain a molecular fingerprint of the tissue. What is

incredible is that through this simple and gentle

chemical process, the MasSpec Pen rapidly provides

diagnostic molecular information without causing

tissue damage.”

The surgeon can simply point the device at a suspect

piece of tissue and can get an indication as to whether

the tissue is cancerous or healthy within 10 seconds,

and in tests the device was 96 per cent accurate. The

technology is similar to another surgical probe that

featured previously onMedgadget, which instead used

Raman and fluorescence spectroscopy to analyze

tissues during surgery, and one that is already cleared

by the FDA that relies on measuring how an electric

current passes through tissues. In any case, it is

encouraging that multiple research groups are

developing this type of technology, which should

significantly help improve surgical treatments for

cancer.

Researchers at the University of Texas at Austin have

developed a hand-held surgical “pen” that can analyze

tissue samples and tell a surgeon if they are cancerous

in just a few seconds, a report from Medgadget said.

During surgery to remove a tumor, surgeons need to

know if they have removed the entire tumor margins, as

leaving just a small piece of neoplasm could mean that

it grows back. Often the tumor looks very similar to

healthy tissue, making it difficult to distinguish, and a

surgeon will sometimes remove large areas of healthy

tissue to make sure that they remove all the cancerous

cells. This can cause unnecessary pain and prolonged

recovery for cancer patients after surgery.

One solution is to take biopsies from areas at the

tumour border during surgery and check if they are

cancerous in the lab. This can take 30 minutes or longer,

and meanwhile, the patient risks infection and an

increased chance of adverse effects from anaesthetics

while they wait on the operating table. In many cases

the results are provided only after surgery, often

necessitating another procedure.

The new MasSpec Pen works using mass spectrometry

to analyze and identify molecules produced during

metabolism within cells. These metabolites can act as

hallmarks for different types of cancer.

“Cancer cells have dysregulated metabolism as they're

growing out of control,” says Livia Schiavinato Eberlin,

a scientist involved in the research. “Because the

metabolites in cancer and normal cells are so different,

we extract and analyze them with the MasSpec Pen to

Surgical pen can detect cancer in seconds

35

Bio/Pharma Product Launch SummitBoston, USA11-12 Septemberhttp://www.cbinet.com/conference/pc17225

14th World Pediatrics ConferenceLos Angeles, USA11-12 Septemberhttp://pediatrics.cmesociety.com

World Drug Safety Congress EuropeBerlin, Germany12-13 Septemberterrapinn.com/conference

8th Arab Diabetes Forum 20-22 SeptemberCairo, Egyptarabicdiabeticforum.com

Building Healthcare Exhibition and Conference11-13 SeptemberDubai, UAEbuildinghealthcare-exhibition.com

17th Dermatology Congress25-26 SeptemberDubai, UAEeventbrite.com

12th Pharma Middle East Congress25-26 SeptemberDubai, UAEhttp://middleeast.pharmaceuticalconferences.com

International Conference on Fungal Diseases & Control25-27 SeptemberDubai, UAEfungalinfections.conferenceseries.com

11th Global Ophthalmologists Annual Meeting25-27 SeptemberDubai, UAEhttp://annualmeeting.conferenceseries.com/ophthalmologists

10th World Paediatric Congress28-29 SeptemberDubai, UAEhttp://pediatriccongress.conferenceseries.com/

Events CALENDAR

23rd World Nurse Practitioner Conference28-29 SeptemberDubai, UAEhttp://nursepractitioner.nursingconference.com/middleeast

Moscow MedShow29-30 SeptemberMoscow, Russiamedshow.ru

7th International Conference on Traditional & Alternative Medicine3-6 OctoberDubai, UAEtraditionalmedicine.conferenceseries.com

International Conference on Healthcare and Life Science Research13-14 OctoberDubai, UAEhttps://iaphlsr.org

4th International Conference on Rhinology and Otology18-20 OctoberDubai, UAEotolaryngology.conferenceseries.com

14th Global Obesity Meeting 23-24 OctoberDubai, UAEobesitymeeting.conferenceseries.com

10th International Conference on Neuropharmacology and Neuropharmaceuticals23-24 OctoberDubai, UAEneuro.pharmaceuticalconferences.com/middleeast/

Patient Safety24-26 OctoberDubai, UAEpatientsafety-me.com

International Society of Addiction Medicine Conference26-20 OctoberAbi Dhabi, UAEwww.isam2017abudhabi.ae Annual Radiology Meeting5-7 NovemberDubai, UAEhttp://radiologyuae.com

8th Global Obesity Conference 14-15 NovemberDubai, UAEobesitymeeting.conferenceseries.com

8th World Congress on Healthcare and Medical Tourism17-18 NovemberDubai, UAEhealthcare.global-summit.com/middleeast/

5th International Conference on Physiotherapy27-28 NovemberDubai, UAEphysiotherapy.conferenceseries.com

International Conference on Cancer Diagnostics27-28 NovemberDubai, UAEcancerdiagnostics.conferenceseries.com/middleeast

22nd Global Vaccines & Vaccination Summit30 Nov-1 DecDubai, UAEvaccines.global-summit.com/middleeast

Global Cancer Meet and Expo 4-6 DecemberDubai, UAEhttps://globalcancermeet.com

29th World Psychiatrist Meet 7-9 DecemberDubai, UAEhttp://psychiatrist.conferenceseries.com

25th Global Diabetes Summit and Medicare Expo11-12 DecemberDubai, UAEdiabetesexpo.com/middleeast

10th International Conference on Gastroenterology14-15 DecemberDubai, UAEgastroenterology.conferenceseries.com/asiapacific

7th International Society of Nephrology13-16 DecemberDubai, UAEnephrology.emanuae.com

Events & Calendar

36

Quick References

www.gulfdental.com

Gulf Diabetes Specialist Center Tel:+973 17 239 239info@gulfdiabetes.comwww.gulfdiabetes.com

King Hamad University Hospital Tel: +973 17 444 444www.khuh.org.bh

Noor Specialist Hospital +973 17 260 026

Kingdom of Saudi Arabia

Al Iman Public Hospital 011-447-1900

King Faisal Specialist Hospital and Research Center Tel: 1990099 Ext 121

Imam Abdul Rahman bin Faisal Hospital Tel:013-858-1111

King Abdul Aziz University Hospital Tel: 012-640-1000

King Fadh Hospital Tel: 012-660-6111

Maternity & Children's Hospital (Jeddah) Tel: 012-665-1636

KUWAIT

Al Zuhair Medical Center Tel:+965- 2224 8777Al Rashid Hospital Tel: +965- 2562 4000

Dar Al Shifa Hospital Tel:+965-1802 555

Al Sabah NBK Pediatric Hospital Tel: +965 4833618 Fax: +965 4814977

Hadi Hospital Tel:+965 1828282www.hadiclinic.com

London Hospital Tel:+965 883883

New Mowasat Hospital Tel:+965 1826666 www.newmowasat.com

Quick References

BAHRAIN

Royal Bahrain Hospital Tel: +973 17 246 800www.royalbahrainhospital.com

KIMS Bahrain Medical Centre Tel:+973 17 822 123kimsbhrn@batelco.com.bhwww.kimsbh.com

Dr. Sulaiman Al-Habib Medical Center Tel: +973 77 310 000

Al-Amal Hospital Tel.:+973 17 602 602admin@alamal-hospital.orgwww.alamal-hospital.org

Al-Hilal Hospital Tel:+973 17 344 700Email: info@alhilalhospital.comwww.alhilalhospital.com

Al-Kindi Specialised Hospitalinfo@alkindihospital.comwww.alkindihospital.com

American Mission Hospital Tel: +973 17 790 025www.amh.org.bh

Awali Hospital Tel: +973 17 753 300

Bahrain Defence Force Hospital (also known as Bahrain Royal Medical Services or Military Hospital) Tel: 973 17 766 666www.bdfmedical.org

Bahrain Specialist Hospital Tel: +973 17 812 080bshinfo@bsh.com.bhwww.bsh.com.bh

Dr. Tariq Saeed Hospital Tel:+973 17 822822Email: tariplas@batelco.com.bhwww.dermaplast.com.bh

German Orthopedic Hospital Tel: +973 17 239 988Email: info@germanortho.comwww.germanortho.com

Gulf Dental Specialty Hospital Tel: +973 17 741 444Email: denthosp@batelco.com.bh

OMAN

Starcare Hospital Tel: +968 24557200Email: info@starcarehospital.comwww.starcarehospital.com

Al Hayat Hospital Tel: 22 004 000www.alhayathospital.com

Hatat Polyclinic Tel: +968 24-563641/2/3

Al Raffah Hospital Tel: +968 24618900/1/2/3/4www.dmhealthcare.com

Badr Al Samaa Hospitals Tel: +968 2 479 9760

Barka Branch Tel:+968 26884918www.badralsamaahospitals.com

Kim's Oman Hospital Tel:+968 24760100 / 200 / 300www.kimsoman.com

Atlas Healthcare Tel: +968 2 450 2560www.healthcare.atlasera.com

The Royal Hospital Tel: Oman – (+968) 24.59.90.00www.royalhospital.med.om

Sultan Qaboos University Hospital Patient Services Department: Tel: 00968 - 24415747 Operator: 00968 - 24413355 extension 4625 during working hourswww.squ.edu.om

Lama Polyclinic Tel: +968 24799077 www.lamapolyclinicoman.com

Muscat Private Hospital Tel: (+968) 24583600www.muscatprivatehospital.com

Apollo Medical Center Tel: (+968) 24787766 / 24782666 / 24787780www.apollomuscat.com

Sultan Qaboos Hospital (Salalah) Tel: +968 2 321 1555

37

Quick References

Adam Hospital Tel: +968- 244 - 25434055

Al Buraimi Hospital Tel: +968 25652319

Al Nahdha Hospital Tel: +968 24837800

QATAR

Al Khor General Hospital Tel:+974 4474 5555

Children's Emergency Centre (Al Sadd) Hotline: +974 4439 6059; +974 4439 2948

Al Amal Oncology Hospital (cancer treatment) Tel: +974 4439 7800

Hamad General Hospital (includes Accident and Emergency) Tel: +974 5584 7803

Rumailah Hospital Tel:+974 4439 3333 www.hmc.org.qa/en/

Al Ahli Hospital Tel:+974 4489 8888 www.ahlihospital.com

Al-Emadi Hospital Tel: +974 4466 6009 www.alemadihospital.com.qa

UAE

PUBLIC HOSPITALS

Rashid Hospital Dubai Tel: 04-2192000

Dubai Hospital, Dubai Tel: +971- 4-2195000; 04-2714444 dhweb@dohms.gov.ae

Latifa Ho spital, Dubai Tel: 04-2193000

Al Maktoum Hospital Tel: 04-222 1211

Al Amal Hospital, Dubai Tel: 04-344 4010

Hatta Hospital

Sha'biah, Hatta, UAE Tel: 04-2195000; 04-814 7000

Police Post-Shaikh Khalif Hospital, Ajman

Call: 06 7050231 www.ajmanpolice.gov.ae

PRIVATE HOSPITALS Al Amanah Medical Center Sharjah Tel: 06 5615545 www.alamanahmedicalcenter.com

American Hospital Dubai

Tel: +971 4 336 7777 – Oud Metha

+971 4 336 7777 – Dubai Media City

Salama Hospital, Abu Dhabi Tel: 02 6966777

Dibba Fujairah Hospital

Tel: 09 2446666

Near Dibba Police Station, 10 Dibba, Fujairah

Al Sharq International Hospital Tel: 09 2249999

Burjeel Hospital

Tel: 04 4070100 joseph.karama@amberclinics.com

Mediclinic Welcare Hospital Tel: - 04-282 7788

Lifeline hospital (Jebel Ali Hospital) Tel: 800 4677 4825 (toll free), +971 4 8845777

Iranian Hospital Tel: 04-344 0250

Belhoul Speciality Hospital Tel: +9714-2140399, +9714-2733333, +9714-2140257

Medcare Orthopaedics and Spine Hospital Tel: - 04-3768 400

Canadian Specialist Hospital Tel: +9714-336 4444, +9714-7072222

Mediclinic City Hospital Tel: +971 4 435 9999

Cedars Jebel Ali Hospital Tel: +9714-8814000, +9714-8818816

Neuro Spinal Hospital Tel: +971 4 3420000 +971 4 3157777

Zulekha Hospital Tel: - 6005 24442; +9714-2678866

Al Zahra Private Hospital Tel: +971 6 516 8902 / 7081

Royal Hospital Tel: +971 6 5452222

Central Private Hospital Tel: 06-563 9900

PHARMACIES

Aster Pharmacies Toll Free# 800-700-600 Head Office: +971 4 3092900

Life Pharmacy, Dubai Branch Tel: 04 222 5503

Makkah Pharmacy - Sharjah

Call: 06 565 6994

OPEN 24 HOURS

Police 999

Dubai Police Call Centre 901

Dubai Police (Non-Emergency) Tel: 04-609 6999

Sharjah Police Tel: 06-563 3333

Ajman Police Tel: +971 6 740 9999

Fujairah Police Tel: 09-222 4411

Ras Al Khaimah Police Tel: 07-235 6666

Umm Al Quwain Police Tel: 06-765 6677

Directory Enquiry Services Etisalat - 181 Du - 199

Disclaimer: Contact details in this section are for reference only. For any inquiries, please get in touch with the relevant authorities and entities directly as the contact details such as telephone numbers, email IDs and website addresses may change in time.